Asymchem Laboratories Tianjin Co (HKSE:06821) 3-Year Book Growth Rate : 38.90% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Asymchem Laboratories Tianjin Co 3-Year Book Growth Rate?

Asymchem Laboratories Tianjin Co's Book Value per Share for the quarter that ended in Sep. 2024 was HK$49.74.

During the past 12 months, Asymchem Laboratories Tianjin Co's average Book Value per Share Growth Rate was -4.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was 38.90% per year. During the past 5 years, the average Book Value per Share Growth Rate was 50.10% per year. During the past 10 years, the average Book Value per Share Growth Rate was 37.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Asymchem Laboratories Tianjin Co was 65.10% per year. The lowest was -0.70% per year. And the median was 30.50% per year.

Competitive Comparison of Asymchem Laboratories Tianjin Co's 3-Year Book Growth Rate

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asymchem Laboratories Tianjin Co's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's 3-Year Book Growth Rate falls into.

Asymchem Laboratories Tianjin Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Asymchem Laboratories Tianjin Co (HKSE:06821) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Asymchem Laboratories Tianjin Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Asymchem Laboratories Tianjin Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (HKSE:06821) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

002821:China

Address

No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457

Website

https://www.asymchem.com

Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.

Executives

Citigroup Inc.	2201 Interest of corporation controlled by you
Schroders Plc	2102 Investment manager
Norges Bank	2101 Beneficial owner
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Fmr Llc	2201 Interest of corporation controlled by you
Fidelity Investment Trust	2101 Beneficial owner
Springhill Fund Asset Management (hk) Company Limited	2102 Investment manager
Springhill Fund Limited	2201 Interest of corporation controlled by you
Springhill Global Feeder Fund Limited	2201 Interest of corporation controlled by you
Springhill Master Fund Limited	2101 Beneficial owner
Morgan Stanley	2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd.	2102 Investment manager
Hhlr Fund, L.p.	2101 Beneficial owner
Jpmorgan Asset Management (asia Pacific) Limited	2102 Investment manager
Fidelity Management & Research Company Llc

Asymchem Laboratories Tianjin Co Headlines

No Headlines